...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: Operative results and preliminary oncologic outcomes from a multicentre French study
【24h】

Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: Operative results and preliminary oncologic outcomes from a multicentre French study

机译:机器人辅助的腹腔镜肾保留肾手术治疗4厘米以上的肿瘤:多中心法国研究的手术结果和初步肿瘤学结果

获取原文
获取原文并翻译 | 示例

摘要

Objective To assess operative and pathological results obtained after robot-assisted partial nephrectomy (RAPN) in renal masses over 4 cm. Patients and methods Between 2007 and 2011, 220 robotic nephron-sparing surgeries (NSS) were performed at six French urology departments. Data were prospectively collected: age, BMI, pre and post-operative eGFR (MDRD), operative time (OT), warm ischemia time (WIT), estimated blood loss (EBL), length of hospital stay (LOS), Clavien complications, pathological results and oncologic outcome. Tumor complexity was assessed according to the RENAL nephrometry score. Results Overall, 54 tumors were included. Median follow up was 26 months. Median age at surgery was 62 years. Median RENAL nephrometry score was 7 (4-10). Median WIT was 23 min (10-59). Median OT and EBL were 180 min (110-425) and 100 cc (0-2500). Blood transfusion occurred in 7 cases (13%). Median tumor size was 45 mm (40-70). Three patients had positive surgical margins. Median LOS was 5 days (2-28). Nine patients presented post-operative complications of which 1/3 were considered as major (Clavien IIIb). Median pre-operative and post-operative eGFR was 88 (36-136) and 75 ml/min (33-122) (p = 0.01), respectively. Two patients developed subsequent metastasis. The 2-year progression free survival (PFS) rate was 90.5%. Conclusion Our results confirm that RAPN is a useful and acceptable approach for renal masses greater than 4 cm in size. When technically possible, NSS provides promising short-term cancer-specific survival rates with acceptable morbidity. Tumor size is not sufficiently discriminant enough and RENAL nephrometry score should increasingly used to describe tumor complexity.
机译:目的评估机器人辅助部分肾切除术(RAPN)对4 cm以上肾脏肿块的手术和病理结果。患者和方法在2007年至2011年之间,法国的六个泌尿科进行了220例机器人保留肾单位手术(NSS)。前瞻性收集数据:年龄,BMI,术前和术后eGFR(MDRD),手术时间(OT),缺血性温暖时间(WIT),估计失血量(EBL),住院时间(LOS),Clavien并发症,病理结果和肿瘤结果。根据RENAL肾功能评分评估肿瘤的复杂性。结果总体上,包括54个肿瘤。中位随访时间为26个月。手术中位年龄为62岁。 RENAL肾功能评分中位数为7(4-10)。 WIT中位数为23分钟(10-59)。 OT和EBL中位数为180分钟(110-425)和100 cc(0-2500)。输血7例(13%)。中位肿瘤大小为45毫米(40-70)。三例患者的手术切缘阳性。 LOS的中位数为5天(2-28)。 9名患者出现了术后并发症,其中1/3被认为是主要并发症(Clavien IIIb)。术前和术后eGFR的中位数分别为88(36-136)和75 ml / min(33-122)(p = 0.01)。两名患者随后发生转移。 2年无进展生存率(PFS)为90.5%。结论我们的结果证实RAPN对于大于4 cm的肾脏肿块是一种有用且可接受的方法。当技术上可行时,NSS可提供有希望的短期特定癌症的生存率,并具有可接受的发病率。肿瘤的大小尚不足以判别,因此应越来越多地使用RENAL肾功能评分来描述肿瘤的复杂性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号